Rice Hall James & Associates’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14M Buy
392,241
+3,446
+0.9% +$107K 0.51% 54
2025
Q4
$17.2M Sell
388,795
-6,760
-2% -$379K 0.95% 34
2025
Q3
$28.9M Sell
395,555
-35,852
-8% -$2.34M 1.58% 15
2025
Q2
$26.5M Sell
431,407
-3,467
-0.8% -$193K 1.43% 21
2025
Q1
$25.2M Sell
434,874
-32,786
-7% -$2.07M 1.48% 19
2024
Q4
$25M Sell
467,660
-133,151
-22% -$6.52M 1.37% 20
2024
Q3
$26.2M Sell
600,811
-122,555
-17% -$4.09M 1.42% 19
2024
Q2
$20.2M Sell
723,366
-51,078
-7% -$1.35M 1.21% 20
2024
Q1
$20.8M Buy
774,444
+30,426
+4% +$867K 1.19% 20
2023
Q4
$20.9M Sell
744,018
-13,268
-2% -$313K 1.21% 21
2023
Q3
$16.1M Sell
757,286
-16,491
-2% -$450K 1.02% 25
2023
Q2
$26.3M Sell
773,777
-12,255
-2% -$408K 1.49% 16
2023
Q1
$25.5M Buy
786,032
+246,955
+46% +$8.19M 1.45% 15
2022
Q4
$18.1M Buy
539,077
+334,166
+163% +$10.2M 1.04% 25
2022
Q3
$6.19M Buy
+204,911
New +$7.51M 0.36% 66

Other funds holding DOCS

Rice Hall James & Associates's DOCS Position: Q1 2026 in Review

Rice Hall James & Associates increased its Doximity (DOCS) stake by 0.89% in Q1 2026, buying an estimated $107K and bringing the position to 392,241 shares worth $9.14M. The position accounts for 0.51% of the portfolio, ranked #54.

Rice Hall James & Associates first reported a position in DOCS in Q3 2022 and has held it in 15 quarters since. The position peaked at $28.9M in Q3 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Rice Hall James & Associates held 392,241 shares of Doximity worth $9.14M as of Q1 2026.
  • Rice Hall James & Associates bought 3,446 Doximity shares in Q1 2026, an estimated $107K.
  • Doximity made up 0.51% of Rice Hall James & Associates's portfolio in Q1 2026, its #54 holding.
  • Rice Hall James & Associates first reported a position in Doximity in Q3 2022 and has held it in 15 quarters since.
  • Rice Hall James & Associates's Doximity position peaked at $28.9M in Q3 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.